SG153894G - Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient - Google Patents

Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Info

Publication number
SG153894G
SG153894G SG153894A SG153894A SG153894G SG 153894 G SG153894 G SG 153894G SG 153894 A SG153894 A SG 153894A SG 153894 A SG153894 A SG 153894A SG 153894 G SG153894 G SG 153894G
Authority
SG
Singapore
Prior art keywords
embonate
azelastin
active ingredient
pharmaceutical compositions
preparation
Prior art date
Application number
SG153894A
Inventor
Gerhard Dr Scheffler
Dieter Sauerbier
Juergen Dr Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DE3850044T priority Critical patent/DE3850044D1/en
Priority to EP88117969A priority patent/EP0316639B1/en
Priority to ES88117969T priority patent/ES2053679T3/en
Priority to DE3836749A priority patent/DE3836749A1/en
Priority to AT88117969T priority patent/ATE106883T1/en
Priority to CA000582812A priority patent/CA1317595C/en
Priority to DK630088A priority patent/DK170339B1/en
Priority to JP63285946A priority patent/JP2730581B2/en
Priority to US07/598,742 priority patent/US5232919A/en
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Priority to SG153894A priority patent/SG153894G/en
Priority to HK135494A priority patent/HK135494A/en
Publication of SG153894G publication Critical patent/SG153894G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Azelastine embonate and pharmaceutical compositions which contain azelastine embonate as the active ingredient.
SG153894A 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient SG153894G (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
EP88117969A EP0316639B1 (en) 1987-11-13 1988-10-28 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
ES88117969T ES2053679T3 (en) 1987-11-13 1988-10-28 AZELASTINE EMBONATE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING AZELASTIN EMBONATE AS AN ACTIVE SUBSTANCE.
DE3836749A DE3836749A1 (en) 1987-11-13 1988-10-28 Azelastine embonate, process for its preparation and pharmaceutical preparations which contain azelastine embonate as an active ingredient
AT88117969T ATE106883T1 (en) 1987-11-13 1988-10-28 AZELASTINE EMBONATE, PROCESS FOR ITS PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING AZELASTINE EMBONATE AS THE ACTIVE SUBSTANCE.
DE3850044T DE3850044D1 (en) 1987-11-13 1988-10-28 Azelastine embonate, process for its preparation and pharmaceutical preparations containing azelastine embonate as active ingredient.
CA000582812A CA1317595C (en) 1987-11-13 1988-11-10 Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as an active substance
DK630088A DK170339B1 (en) 1987-11-13 1988-11-11 Azelastine Embonate, Method of Preparation, Preparations Containing, and Stable, Aqueous Suspensions of this Compound, and Use of Azelastine Embonate in the Preparation of Medicines
JP63285946A JP2730581B2 (en) 1987-11-13 1988-11-14 Azelastine embonate, process for its preparation, preparation for oral administration containing the compound, stable aqueous suspension and aerosol, process for preparing these and suspension for oral administration and process for preparation of solid preparation
US07/598,742 US5232919A (en) 1987-11-13 1990-10-15 Azelastine embonate and compositions which contain it
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
HK135494A HK135494A (en) 1987-11-13 1994-12-01 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Publications (1)

Publication Number Publication Date
SG153894G true SG153894G (en) 1995-03-17

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient

Country Status (9)

Country Link
EP (1) EP0316639B1 (en)
JP (1) JP2730581B2 (en)
AT (1) ATE106883T1 (en)
CA (1) CA1317595C (en)
DE (1) DE3850044D1 (en)
DK (1) DK170339B1 (en)
ES (1) ES2053679T3 (en)
HK (1) HK135494A (en)
SG (1) SG153894G (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0396069B1 (en) * 1989-05-05 1994-06-22 ASTA Medica Aktiengesellschaft Salts of azelastine having advanced solubility
JPH04198180A (en) * 1990-11-28 1992-07-17 Eezai Kagaku Kk Production of benzylphthalazone derivative
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
DK2377557T3 (en) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Compositions comprising azelastine and methods for its use
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (en) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
DE3850044D1 (en) 1994-07-14
EP0316639A2 (en) 1989-05-24
EP0316639A3 (en) 1990-07-18
DK630088D0 (en) 1988-11-11
JPH01153686A (en) 1989-06-15
ES2053679T3 (en) 1994-08-01
DK170339B1 (en) 1995-08-07
ATE106883T1 (en) 1994-06-15
CA1317595C (en) 1993-05-11
JP2730581B2 (en) 1998-03-25
HK135494A (en) 1994-12-09
EP0316639B1 (en) 1994-06-08
DK630088A (en) 1989-05-14

Similar Documents

Publication Publication Date Title
TW229208B (en)
UA32512C2 (en) Xanthine derivatives, a PROCESS for PREPARATION thereof and A pharmaceutical composition
IL84446A0 (en) 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
DE59001121D1 (en) Antacidatabletten.
HK135494A (en) Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
IL61989A (en) 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them
TW218011B (en)
AU8452891A (en) Calcium uptake inhibitors
IE883402L (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance
UA32583C2 (en) Derivatives of arylthioalkylthiopyridine
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
JO1531B1 (en) Novel pharmacological compounds
JO1843B1 (en) Subsituted benzimidazole procisses for its preparation and its phrmaceutical use
JO1519B1 (en) Novel compounds (Novel deravatives of Benzimidazoles active as anti-ulcer agents).
IE873354L (en) New pyrrolobenzimidazoles, processes for the preparation¹thereof and pharmaceutical compositions containing them.